David Leigh is a Professor in Organic Chemistry at the University of Manchester , UK. He has held prestigious positions including the Sir Samuel Hall Chair (2014–present), Forbes Chair at the University of Edinburgh (2001–2012), and Chair of Synthetic Chemistry at the University of Warwick (1998–2001). His research focuses on synthetic molecular machines, supramolecular chemistry, and molecular knots. Fields of Scholarship : Synthetic molecular machines, Synthetic molecular knots and links, Supramolecular chemistry His work includes creating hydrogen-bonded molecular rotors , reversible rotary molecular motors , and artificial ribosome mimics . Article trends highlight nanotechnology , molecular engineering , and self-assembly advancements. Scientific Awards : Royal Society of Chemistry Pedler Award (2014), ERC Advanced Grant (2014), Bakerian Prize (2013), Tilden Prize (2010), Fellow of the Royal Society (2009), etc. Leigh has led groundbreaking projects funded by the European Research Council (2008, 2014) and held an EPSRC Senior Research Fellowship (2005–2010). His lab at the University of Manchester explores bottom-up molecular design and stimuli-responsive systems.
Kelly Arnold is an Associate Professor in the Department of Biomedical Engineering at the University of Michigan. Her research integrates systems engineering principles with immunology to investigate variability in immune responses across infection, vaccination, and injury, with a focus on computational modeling and clinical translation. Research Focus Systems-level immune response modeling Vaccination and antibody functionality Vaginal microbiome-host interactions Chronic lung disease progression Computational serology and proteomics Recent Work Her 2025 studies examine SARS-CoV-2 vaccination responses in cancer patients and computational frameworks for vaginal probiotics. Earlier works (2024-2007) span COPD progression, lupus fibrosis, HIV susceptibility, and tissue engineering for fertility preservation. Methodologies include proteomic profiling, network modeling, and microfluidic systems.
Randy H. Ewoldt is the Alexander Rankin Professor in the Department of Mechanical Science and Engineering at the University of Illinois at Urbana-Champaign (UIUC), part of the Grainger College of Engineering. He holds the Kritzer Faculty Scholar distinction and has been a faculty member since 2011, progressing from Assistant to Associate Professor before his current rank. His research focuses on fluid mechanics and rheology of complex fluids, with interdisciplinary applications in bioengineering, manufacturing, and robotics. Education includes a PhD and MS in Mechanical Engineering from MIT (2009 and 2006) and a BS from Iowa State University (2004). He has held visiting roles, including Guest Professor at ETH Zurich (2018). Research interests span rheology of complex fluids, nonlinear viscoelasticity, and material design. Notable contributions include pioneering work on protorheology and yield-stress fluids. His work often combines experiment and theory, emphasizing practical applications. Awards include the 2025 Society of Rheology Fellowship, PECASE (2017), and multiple teaching accolades. He advises on advanced fluid mechanics and rheology courses, including TAM 435, TAM 534, and ME 310. Labs/Teams: Ewoldt Research Group focuses on fluid mechanics and rheology, collaborating on projects like 3D printing and material design. Recent highlights include studies on embedded solvent exchange printing and viscoelastic fluid behavior.
Prof. Dr. Helmuth Gehart is a faculty member at the Institute of Molecular Health Sciences , ETH Zurich . He leads the Tumor and Stem Cell Dynamics research group, focusing on dynamic cell identity in regeneration and cancer. Research Interests : Stem cell-environment interactions, organoid technology, single-cell sequencing, and mechanisms of tissue repair/tumorigenesis. Publications : 10+ articles (2015-2024) on organoid models, stem cell dynamics, and cancer biology.
Changhuei Yang is the Thomas G. Myers Professor of Electrical Engineering, Bioengineering, and Medical Engineering at California Institute of Technology, serving as Executive Officer for Electrical Engineering and Investigator at Heritage Medical Research Institute. He holds a Ph.D. and three master's degrees from MIT, with appointments at Caltech since 2003. Research focuses on: Advanced microscopy techniques including Fourier Ptychography Wavefront shaping for biological tissue imaging Optical phase conjugation for deep-tissue applications Compact medical devices for cerebral monitoring Publications demonstrate leadership in computational imaging, with recent advances in stain-free embryo analysis, portable cerebral blood flow monitors, and high-resolution volumetric imaging techniques using neural representations. Honored as National Academy of Inventors member. Research applications span deep-tissue biochemical imaging, incisionless surgery, and optogenetic activation systems.
Prof. Vasilis Ntziachristos is a Professor and Chair of Biological Imaging at the Technical University of Munich (TUM), leading the Institute of Biological and Medical Imaging at the Helmholtz Centre Munich. His research focuses on developing novel optical and optoacoustic imaging techniques for early disease detection, diagnostics, and theranostics. He holds a PhD in Bioengineering from the University of Pennsylvania and previously served as an Assistant Professor at Harvard University and Massachusetts General Hospital. Affiliations: TUM School of Medicine and Health, Helmholtz Munich, Institute of Biological and Medical Imaging. Key Research Themes: Non-invasive imaging methods, molecular imaging, optoacoustic technology, and clinical translation. His work bridges theoretical developments with clinical applications, including advancements in glucose monitoring, cancer imaging, and drug delivery systems. Notable awards include the Leibniz Prize (2013) and the World Molecular Imaging Society Gold Medal (2015). Labs/Teams: Imaging to Sensing I2S, Optoacoustic Mesoscopy, Fluorescence Imaging, and AI in Optoacoustics. Grants/Projects: Involvement in Horizon Europe initiatives and collaborations with TranslaTUM and Helmholtz Munich. Prof. Ntziachristos actively contributes to education via courses like 'Biological Imaging' and 'Introduction to Bioengineering', fostering the next generation of imaging scientists.
Weiqiang Chen is a Professor of Mechanical and Biomedical Engineering at New York University's Tandon School of Engineering and Director of Research and PhD Programs. He holds a joint appointment at NYU Langone's Perlmutter Cancer Center as a Faculty Member of the Tumor Immunology Research Program. B.S. in Physics (Nanjing University, 2005) M.S. in Electrical Engineering (Shanghai Jiao Tong University, 2008) M.S. in Electrical and Computer Engineering (Purdue University, 2009) Ph.D. in Mechanical Engineering (University of Michigan, 2014) His research focuses on Lab-on-a-Chip , Organ-on-Chip systems, Biomaterials , and Mechanobiology , with applications in cancer biology, stem cell engineering, and immune monitoring. He pioneers microfabrication technologies for real-time observation of cellular interactions, including CAR T-cell immunotherapy efficacy and tumor microenvironment dynamics. Recent grants include NSF funding for leukemia bone marrow niche modeling, NIH Trailblazer Awards for glioblastoma immunotherapy research, and collaborations with the Arthritis Foundation for synovium-on-chip rheumatoid arthritis studies. His work has been supported by over $2M in federal and institutional research funding. National Science Foundation (NSF) grants for leukemia-on-chip and glioblastoma modeling National Institutes of Health (NIH) awards for immunotherapy research American Heart Association fellowships and institutional training programs Chen's scientific awards include the American Heart Association Fellow distinction, multiple Young Investigator Awards from Lab on a Chip and Biomedical Engineering Society, and recognition for his dissertation on nanotopography in stem cell differentiation. He leads the Applied Micro-Bioengineering Laboratory (AMBL) , which develops microphysiological systems for drug testing and personalized medicine. His team has created the first immunocompetent leukemia-on-a-chip for CAR T-cell therapy screening and glioblastoma models that enable patient-specific immunotherapy validation.
Alan Stocker is a Professor in the Department of Psychology at the University of Pennsylvania, affiliated with the Neuroscience Graduate Group, Bioengineering Graduate Group, and Computational Neuroscience Initiative. His research focuses on understanding how prior beliefs and expectations shape visual perception, combining theoretical models with psychophysical and physiological experiments. Key areas include optimal inference frameworks, neural coding efficiency, and decision-making under uncertainty. Education: PhD in Physics (ETH Zurich, 2002); MSc in Biomedical Engineering and Materials Science (ETH Zurich, 1995). Prior appointments include postdoctoral work at New York University and ETH Zurich. Research Interests: Behavioral Neuroscience, Cognitive Neuroscience, Sensation and Perception. Specific projects explore statistical properties of visual environments, subjective expectations from past decisions, and neural computations underlying perception. Advising: Current advisees include Cheng Qiu (Postdoc), Ansh Soni, and Mengting Fang (Graduate Students). Courses taught: Perception, Visual Neuroscience, and Probabilistic Models in Perception and Cognition. Labs/Teams: Leads the Computational Perception and Cognition (CPC) Laboratory, emphasizing theory-driven experimentation. Collaborates widely across disciplines including bioengineering and electrical systems engineering.
Wenyao Xu is a Professor and Associate Department Chair in the Department of Computer Science and Engineering at the University at Buffalo, School of Engineering and Applied Sciences. His research focuses on embedded systems, body sensor networks, biomedical signal analytics, telemedicine, and human-computer interaction. He leads the Embedded Sensing and Computing (ESC) Lab, pioneering innovations in wearable health monitoring and non-invasive medical technologies. Dr. Xu holds a PhD in Electrical and Electronics Engineering from UCLA (2013), an MEng in Embedded Systems from Zhejiang University (2008), and a BEng in Electrical Engineering from Zhejiang University (2006). He has received multiple accolades, including the UB Exceptional Scholar—Sustained Achievement Award (2021) and SEAS Senior Career Researcher of the Year (2020). His research spans cutting-edge areas like mmWave-based sensing for health monitoring, mHealth applications for behavioral interventions (e.g., Sense2Quit app for smoking cessation), and wearable devices for gait analysis and vital sign detection. Recent work includes advancements in through-clothing wound monitoring, voice- and gesture-based authentication systems, and AI-enhanced medical imaging. Publications reflect his interdisciplinary impact, with over 150 peer-reviewed papers in top venues. His lab collaborates closely with clinical partners to translate technologies into practical healthcare solutions. Dr. Xu also emphasizes mentorship, having been honored with the President Emeritus and Mrs. Meyerson Award for teaching excellence (2020).
Dr. Sophie Koch is a Lecturer at ETH Zürich's Department of Civil, Environmental and Geomatic Engineering. Her research focuses on bio-based composites, circular wood use, and enhancing wood properties. She leads the research streams 'Enhanced wood properties' and 'Resource-efficient wood utilization.' Education: PhD Candidate (2020-2023): ETH Zurich, Wood Materials Science Group MSc in Biobased Materials (2018-2020): Maastricht University BSc in Wood Technology (2013-2017): UAS Rottenburg Key Research Themes: Her work emphasizes sustainable material innovation through bio-based composites, wood recycling, and functionalization of wood for advanced applications like soft actuators and energy-harvesting systems. Recent publications highlight advancements in transparent wood films, triboelectric nanogenerators, and durable delignified composites. Professional Experience: Postdoctoral Researcher & Lecturer (2024-2024) Master’s Thesis at Swiss Wood Solutions AG (2019-2020) Research Assistant at UAS Rottenburg (2017-2018) Journalist at Holz-Zentralblatt (2014-2017) Labs & Teams: Active in the Professur Holzbasierte Materialien research group at ETH Zürich's HIF E 20.1 laboratory.
Professor Robert McLaughlin is a faculty member in the School of Biomedicine at the University of Adelaide, affiliated with the Faculty of Health and Medical Sciences. He leads the Bioengineering Imaging Group and serves as Managing Director of the start-up Miniprobes. His research focuses on developing optical imaging technologies, including non-invasive tools for blood flow assessment and miniaturized imaging probes. He has secured over $14M in research grants and holds an h-index of 45 with 98 journal papers, 7 patents, and 2 book chapters. Prof. McLaughlin’s career includes roles at the University of Oxford and Siemens Medical Solutions, followed by academic leadership since 2007. His innovations span optical coherence tomography (OCT), fluorescence imaging, and dual-modality systems for clinical applications. Awards include the 2014 WA Innovator of the Year, 2015 Australian Innovation Challenge, and 2016 South Australian Premier’s Research Fellowship. His research emphasizes practical medical solutions, such as imaging needles for deep-tissue diagnostics and optical devices for real-time surgical monitoring. The Bioengineering Imaging Group collaborates with industry and academia to translate technologies into clinical practice.
Virgil Percec is the P. Roy Vagelos Professor of Chemistry at the University of Pennsylvania, affiliated with the School of Arts & Sciences and the Department of Chemistry. His research focuses on organic, supramolecular, and macromolecular chemistry, with an emphasis on self-assembly, drug delivery systems, and biomimetic nanosystems. He holds a B.S. and Ph.D. from institutions in Jassy, Romania, and conducted postdoctoral research at the University of Freiburg and the University of Akron. Research Interests: Percec’s work integrates synthetic methods, catalysis, and structural biology to design functional nanosystems. Key areas include hierarchical folding, supramolecular chirality, and synthetic mimics of biological membranes. His lab explores mRNA delivery systems using Janus dendrimers and studies self-organized structures like helical columns and quasicrystals. Recent Articles: His recent publications highlight advancements in mRNA delivery mechanisms, supramolecular architectures, and polymer synthesis innovations. The group’s work often involves interdisciplinary collaborations, bridging chemistry, materials science, and bioengineering. Awards: Percec was elected a Foreign Member of the Academia Europaea (2020) and delivered the inaugural ACS Kavli Lecture (2011). His lab has trained numerous students and postdocs, including Juncheng Lu (Master’s Capstone Award recipient) and Devendra Maurya (SET-LRP research). Labs & Teams: The Percec Research Laboratory at Penn develops cutting-edge biomaterials and supramolecular systems. The group collaborates globally, with projects funded by grants exploring nanotechnology and drug delivery.
Arash Arami is an Associate Professor in the Department of Mechanical and Mechatronics Engineering at the University of Waterloo, cross-appointed in Systems Design Engineering. He directs the Neuromechanics and Assistive Robotics Laboratory and maintains affiliations with Waterloo Robohub, the Centre for Bioengineering and Biotechnology, Waterloo AI institute, and KITE institute at Toronto Rehab Institute. He earned his Doctorate in Electrical Engineering from EPFL (2014), Master of Science from University of Tehran (2009), and Bachelor of Science from University of Tabriz (2006), all in Control Engineering. His research in Assistive Robotics and Rehabilitation Engineering integrates Machine Learning with Neuromechanics to develop intelligent systems for human movement analysis. Key focus areas include exoskeleton control algorithms, wearable sensor systems, and neural control modeling for rehabilitation applications. Recent publications demonstrate interdisciplinary work spanning robotics, biomedical engineering, and materials science, with emphasis on real-time human locomotion prediction, exoskeleton-human interaction, and data-driven health monitoring solutions. Dr. Arami serves as Chair of the NSERC Scholarship Committee (2021-2023) and mentors graduate students through the Mechatronics Exchange Study program. His teaching includes core courses in control systems, robot manipulators, and biomechanical engineering. The Neuromechanics and Assistive Robotics Laboratory fosters collaborations with clinical partners at Toronto Rehab Institute, focusing on translating robotic innovations into practical rehabilitation tools through interdisciplinary teamwork.
Houman Savoji is an Associate Professor in the Department of Pharmacology and Physiology at the Faculty of Medicine, University of Montreal. He is also a full-time researcher at the CHU Sainte-Justine Research Center and principal investigator in regenerative medicine, organs-on-chip, and bioprinting at TransMedTech Institute. Dr. Savoji received his PhD in Biomedical Engineering from the Institute of Biomedical Engineering at Polytechnique Montréal in 2016. He then completed a postdoctoral fellowship at the Institute of Biomaterials and Biomedical Engineering at the University of Toronto. His research expertise combines advanced manufacturing technologies (micro- and nano-fabrication, 3D bioprinting, microfluidics, cell electrospinning) with functional and composite materials for applications in tissue engineering, regenerative medicine, and organs-on-chip. His work focuses on the design, development, optimization, implementation, and characterization of innovative functional biomaterials using emerging engineering technologies, with particular emphasis on cardiac tissue engineering and biomimetic pulmonary heart valves for pediatric patients. Dr. Savoji has published extensively on biomaterials, tissue engineering, 3D bioprinting, and organ-on-chip technologies. His recent publications demonstrate expertise in viscoelastic characterization of soft tissues, engineering immune responses to biomaterials, ceramic engineering for biomedical applications, and advanced 3D bioprinting techniques for cardiac and vascular tissue engineering. 2017-2020, Postdoctoral Research Grant, CIHR 2017-2019, Postdoctoral Research Grant, FRQNT 2017-2018, Human Society of International Grant, Human Toxicity Assessment Project 2016, CR-CHUM Research Center Award 2015, Star Student-Researcher Award, FRQNT 2014-2015, Jane and Frank Warchol Fellowship, Society of Vacuum Coaters Foundation 2013, Institute of Textile Science Award 2012-2015, Excellence Doctoral Scholarship for Foreign Students, FRQNT Dr. Savoji has supervised Master's students including Ines Barrakad (2024) working on 'Advanced manufacturing technologies versus molding of corneal implants: 3D printing vs molding of a Keratoprosthesis' and Zineb Ajji (2023) researching 'Development of perfusable patches by 3D bioprinting for potential application in cardiac tissue regeneration.' He has secured numerous research grants from organizations including CIHR, NSERC, FRQNT, FRQS, MITACS, and others for projects related to 3D bioprinting of cardiac tissues, biomimetic heart valves, and other tissue engineering applications. The Savoji Laboratory, located within the Department of Pharmacology and Physiology and Institute of Biomedical Engineering of the Faculty of Medicine of the University of Montreal, the Research Center of the CHU Sainte-Justine (CHUSJ), and the TransMedTech Institute, focuses on multidisciplinary research involving 3D bioprinting using stem-cell derived human cardiac cells to fabricate functional cardiac tissues for transplantation and drug discovery applications.
Professor Urs Jenal is a Full Professor at the Biozentrum of the University of Basel, Switzerland, where he has led research on bacterial signal transduction since 2008. His laboratory investigates the molecular mechanisms of bacterial persistence and antibiotic resistance, with particular focus on pathogens causing chronic infections in humans. Previously, he served as Associate Professor (2002-2008) and Assistant Professor (1996-2002) at the same institution, and completed postdoctoral training at Stanford University and ETH Zurich. Education 2000: Habilitation and VENIA DOCENDI in Microbiology, University of Basel 1987-1991: PhD in Molecular Microbiology, ETH Zurich (supervisor: Prof. T. Leisinger) 1982-1986: Studies of Experimental Biology, ETH Zurich 1977-1981: Gymnasium with Matura Type C, Chur Research Focus Prof. Jenal's research centers on understanding how bacterial pathogens persist in the human body despite antibiotic treatments. His laboratory investigates cyclic nucleotides, particularly c-di-GMP, as signaling molecules that control bacterial biofilm formation, virulence, and antibiotic tolerance. His team studies pathogenic Escherichia coli causing recurrent urinary tract infections and Pseudomonas aeruginosa causing long-term lung infections in cystic fibrosis patients. Recent work has revealed how "sleeping" bacteria survive antibiotic treatments and how pathogens breach respiratory epithelia through goblet cell invasion. Scientific Recognition 2014: Elected member of the European Academy of Microbiology (EAM) 2013: ERC Advanced Investigator Award 2012: Elected member of the European Molecular Biology Organization (EMBO) 2011: Elected member of the American Academy of Microbiology (AAM) Mentorship and Collaborations Prof. Jenal has mentored numerous PhD students and postdocs, many receiving awards for their research. His laboratory is part of the NCCR AntiResist initiative focused on developing novel approaches against antibiotic resistance. He collaborates extensively with clinical researchers and has developed innovative models, including human mini-lungs, to investigate pathogen-host interactions. His recent publications demonstrate how understanding bacterial persistence mechanisms can lead to new therapeutic strategies against chronic infections.
